Illumina, Inc.
General ticker "ILMN" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $22.7B
Illumina, Inc. follows the US Stock Market performance with the rate: 33.8%.
Estimated limits based on current volatility of 2.4%: low 131.86$, high 138.34$
Factors to consider:
- Company included in S&P500 list
- China accounted for 11.9% of revenue in the fiscal year ended 2023-01-01
- US accounted for 57.8% of revenue in the fiscal year ended 2023-01-01
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [121.27$, 200.96$]
- 2024-12-30 to 2025-12-30 estimated range: [136.51$, 219.34$]
Financial Metrics affecting the ILMN estimates:
- Negative: Operating profit margin, % of -19.25 <= 1.03
- Positive: 0.10 < Non-GAAP EPS, $ of 0.87
- Negative: negative Net income
- Negative: Industry inventory ratio change (median), % of 1.54 > 0.49
- Positive: Inventory ratio change, % of -0.58 <= 0
Short-term ILMN quotes
Long-term ILMN plot with estimates
Financial data
YTD | 2022-01-02 | 2023-01-01 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $4,526.00MM | $3,965.00MM | $4,484.00MM |
Operating Expenses | $4,649.00MM | $8,144.00MM | $5,553.00MM |
Operating Income | $-123.00MM | $-4,179.00MM | $-1,069.00MM |
Non-Operating Income | $1,007.00MM | $-157.00MM | $-48.00MM |
Interest Expense | $61.00MM | $26.00MM | $77.00MM |
R&D Expense | $1,185.00MM | $1,321.00MM | $1,354.00MM |
Income(Loss) | $884.00MM | $-4,336.00MM | $-1,117.00MM |
Taxes | $122.00MM | $68.00MM | $44.00MM |
Profit(Loss) | $762.00MM | $-4,404.00MM | $-1,161.00MM |
Stockholders Equity | $10,740.00MM | $6,599.00MM | $5,745.00MM |
Inventory | $431.00MM | $568.00MM | $587.00MM |
Assets | $15,217.00MM | $12,252.00MM | $10,111.00MM |
Operating Cash Flow | $545.00MM | $392.00MM | $478.00MM |
Capital expenditure | $208.00MM | $466.00MM | $195.00MM |
Investing Cash Flow | $-1,069.00MM | $-591.00MM | $-231.00MM |
Financing Cash Flow | $-51.00MM | $1,000.00MM | $-1,210.00MM |
Earnings Per Share* | $5.08 | $-28.05 | $-7.35 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.